ZUG, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a…
February 23, 2026 18:15 ET | Source: Supernus Pharmaceuticals, Inc. ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals,…
February 19, 2026 08:00 ET | Source: Zscaler, Inc. SAN JOSE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ:…
NEW DELHI , Dec. 31, 2025 /PRNewswire/ -- Mach Conferences and Events Ltd. (BSE: 544248), a pioneer in the MICE industry,…
November 28, 2025 11:30 ET | Source: Global-e Online Ltd PETACH TIKVAH, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Global-e…
November 11, 2025 07:05 ET | Source: Zenas BioPharma WALTHAM, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.…
November 03, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”,…
September 03, 2025 16:57 ET | Source: vTv Therapeutics Inc. HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- vTv…
ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis…
SAN DIEGO, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), the industry leader in AI-powered analytics and operational…